Details for New Drug Application (NDA): 040719
✉ Email this page to a colleague
NDA 040719 describes METHYLPREDNISOLONE ACETATE, which is a drug marketed by Amneal, Endo Operations, Epic Pharma Llc, Eugia Pharma, Hong Kong, Sagent Pharms Inc, Sandoz, Teva Pharms Usa, Watson Labs, and Wilshire Pharms Inc, and is included in seventeen NDAs. It is available from ten suppliers. Additional details are available on the METHYLPREDNISOLONE ACETATE profile page.
The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
The generic ingredient in METHYLPREDNISOLONE ACETATE is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
Summary for 040719
| Tradename: | METHYLPREDNISOLONE ACETATE |
| Applicant: | Sandoz |
| Ingredient: | methylprednisolone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/ML | ||||
| Approval Date: | Jan 29, 2009 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 80MG/ML | ||||
| Approval Date: | Jan 29, 2009 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
